AXL and familial pancreatic carcinoma: CAB-AXL-ADC demonstrated the ability to induce cytotoxicity of human tumor cell lines expressing AXL in vitro, and inhibit tumor growth in lung, prostate, pancreatic human tumor xenografts, and in selected gemcitabine-resistant pancreatic cancer-derived xenograft models, in vivo (39).